In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung.
about
Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBDFibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine FamilyPulmonary fibrosis: pathogenesis, etiology and regulationEndocytosis of indium-tin-oxide nanoparticles by macrophages provokes pyroptosis requiring NLRP3-ASC-Caspase1 axis that can be prevented by mesenchymal stem cellsAnti-fibrotic actions of interleukin-10 against hypertrophic scarring by activation of PI3K/AKT and STAT3 signaling pathways in scar-forming fibroblastsResistance to bleomycin-induced lung fibrosis in MMP-8 deficient mice is mediated by interleukin-10Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent.Latent infection by γherpesvirus stimulates profibrotic mediator release from multiple cell types.New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axisExpression profiling of genes regulated by Fra-1/AP-1 transcription factor during bleomycin-induced pulmonary fibrosis.Acute adaptive immune response correlates with late radiation-induced pulmonary fibrosis in mice.Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosisSurfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury.IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in miceAerobic Exercise Attenuated Bleomycin-Induced Lung Fibrosis in Th2-Dominant Mice.CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts.PPARγ activation following apoptotic cell instillation promotes resolution of lung inflammation and fibrosis via regulation of efferocytosis and proresolving cytokines.CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.Macrophage heterogeneity in respiratory diseases.Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model.PEG-rIL-10 treatment decreases FoxP3(+) Tregs despite upregulation of intratumoral IDOProtease-activated receptors and prostaglandins in inflammatory lung disease.Matrilysin (Matrix Metalloproteinase-7) regulates anti-inflammatory and antifibrotic pulmonary dendritic cells that express CD103 (alpha(E)beta(7)-integrin).Expression of the immunomodulator IL-10 in type I pneumocytes of the rat: alterations of IL-10 expression in radiation-induced lung damageMadecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting the generation of hepatocyte growth factor via PPAR-γ in colon.The pathogenesis of idiopathic pulmonary fibrosis.Growth factors and cytokines in acute lung injury.Mechanotransduction and fibrosis.The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis.Impact of surgical innovation on tissue repair in the surgical patient.Identifying mechanisms driving formation of granuloma-associated fibrosis during Mycobacterium tuberculosis infection.Lung remodeling associated with recovery from acute lung injury.Attenuation of methylglyoxal-induced peritoneal fibrosis: immunomodulation by interleukin-10.Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injuryRegenerative Wound Healing: The Role of Interleukin-10.IL-10: Another therapeutic target in idiopathic pulmonary fibrosis?Hydrodynamics-based transfection of rat interleukin-10 gene attenuates porcine serum-induced liver fibrosis in rats by inhibiting the activation of hepatic stellate cellsInfant lungs are preferentially infected by adenovirus and herpes simplex virus type 1 vectors: role of the tissue mesenchymal cells.The role of all-trans retinoic acid in bleomycin-induced pulmonary fibrosis in mice.Antifibrotic, Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl-Induced Systemic Sclerosis.
P2860
Q26740540-19E03855-468E-480F-97C9-08CBE4926B9AQ26801150-F45B605A-731F-4911-A1DE-30ACE2338D6BQ28388425-7F64E73F-E29A-4126-AD39-7D36849757F7Q28394649-67F3725D-852E-4DE9-B801-BCFC03026AB3Q28539207-FD4DF013-F403-42BA-A90F-8EE8572EFC2CQ33719352-02C21AED-51E5-4237-AD3B-1B24FBF39CC7Q33730117-DE2CA112-C35A-431F-8174-A17D7CF77AA3Q34598816-7918B441-999E-4DED-89A9-3331F0A375E0Q34720147-EB50CBEE-FA6B-445A-A664-649C399BA2ABQ34768174-9E937ED9-C7FA-40BB-AAC5-0ACCC9272D18Q35125702-09D1AEF2-BC98-405C-AA75-60ECD0540D32Q35151307-F26FC434-A855-46A4-95AA-D88E5B3807CAQ35813675-11AACBDC-C410-4057-B360-37836AAD10CFQ35995705-8AB9078D-A73C-4E63-B329-EF148F90E1BAQ36146139-836DDD9C-541D-4122-A2FE-097D691B1485Q36391220-7DB52F0A-7B26-4CA4-84A6-2CDD96DC3D3FQ36605155-1B1BD63E-8758-4CF4-B66C-7E8DAC0C47B1Q36691117-F07375F0-11F7-4434-8973-35E1F76179B2Q36692041-38293BF1-8E91-4C8C-B240-4C6870F6B244Q37069130-162BF26E-E74A-43C3-973C-6A270890C952Q37222162-EEF0EBFE-F36E-4670-9B74-426BBE38D134Q37447476-9CF84B65-E171-402F-B03F-D147EE40AAA1Q37462672-42B80CBC-BB93-4F57-9052-46F793240B79Q37643117-47B5DF81-F301-4726-87EC-A70C6B3BDFBBQ37686310-04317EB5-8DB9-4AED-AC87-77AE1F5D0B17Q37800756-151C7EE8-7B2C-47E9-ACAE-BCD47AA9CCEAQ38112030-B56E003D-A862-4580-8FBD-06BCF3FD9182Q38202790-E7FB267A-16FE-4C09-B504-CE6C6D27E2C2Q38290539-E4E71073-DA23-4ABA-AEB1-6EB0BC852BB4Q38334682-A9BD7172-8690-4B0B-A866-4275092EE1D1Q38713268-4A0B3761-3202-483B-AA8F-488DBBE56E04Q38994633-9BA1BFDC-047C-4850-BEEF-0D569DC7ACCDQ41363398-9060AA61-D7AB-474D-BEF4-23BC9A1D620AQ41429523-00ACE704-D56C-497B-8B40-AAC4A98D1E3FQ42355553-9C42D005-4E9E-47A4-B2A0-7635E421ACE4Q42744057-F2DE5460-A2DE-49A9-AB82-E08A3B7B44EFQ42768116-4E946AC7-313F-4705-8E63-02EB1691D489Q45369052-340D35C7-3F31-4939-9FA9-E5ADFBA11077Q53191767-FB5FE1DE-D051-4207-B3C4-77DE07068936Q53308983-DE8700D1-135D-4F33-97D7-A04CA9615711
P2860
In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
In vivo IL-10 gene delivery at ...... ation of TGF-beta in the lung.
@en
type
label
In vivo IL-10 gene delivery at ...... ation of TGF-beta in the lung.
@en
prefLabel
In vivo IL-10 gene delivery at ...... ation of TGF-beta in the lung.
@en
P2093
P2860
P356
P1433
P1476
In vivo IL-10 gene delivery at ...... vation of TGF-beta in the lung
@en
P2093
P2860
P304
P356
10.1136/THX.2005.056317
P407
P577
2006-06-29T00:00:00Z